En savoir plus
Klappentext This 1996 volume reviewed advances in the field of human tumour immunology for an audience of clinicians and researchers. Zusammenfassung This 1996 volume reviewed advances in the field of human tumour immunology! particularly in relation to the potential for immune intervention in preventing or treating tumours. The contributors survey advances in the understanding of the relationship between the cancer cell and the immune response at the time of publication. Inhaltsverzeichnis Contributors; Series Editor's Preface; Abbreviations; 1. Introduction and historical perspectives Michael Browning and A. G. Dalgleish; 2. The immunosurveillance of cancer: specific and non-specific mechanisms Richard G. Vile, Heung Chong and Sina Dorudi; 3. Antigen processing and presentation Nicholas C. Testifo and Michael Wang; 4. The role of the MHC class I in tumor immunity Michael Browning; 5. Human tumor antigens recognized by Cytolytic T Lymphocytes Pierre G Coulie; 6. Peptide-specific CTL directed against viral oncogene products Mariet C.W. Feltkamp, Cornelis J. M. Melief and W. Martin Kast; 7. Cellular oncogenes for tumor immunity: immunotherapy Hans J. Strauss and A. Maria Dahl; 8. Co-stimulatory molecules and their role in tumour immunity A. G. Dalgleish; 9. The role of cytokines in tumour rejection Guido Forni and Robin Foa; 10. Inhibition of nonhemopoietic cancer cell growth by Interleukin-4 and related cytokines Dave S. B. Hoon, Takashi Morisaki and Richard Essner; 11. Current concepts concerning melanoma vaccines Donald L. Morton and Mepur H. Ravindranath; 12. Immune responses to mucins Rosalind A. Graham and Joyce Taylor-Papadimitriou; 13. Heat shock protein-peptide complexes: pan-valent vaccines against cancers and infectious diseases Ryuichiro Suto and Pramod K. Srivastave; 14. The potential of gene transfer to alter the immune response to tumors Bernard A. Fox and Gary J. Nabel; 15. Applications of antibody gene technology Robert E. Hawkins and Kerry A. Chester; Index....
